Mononeuropathy Multiplex After COVID-19.
J Clin Neuromuscul Dis
; 23(1): 24-30, 2021 Sep 01.
Article
in En
| MEDLINE
| ID: mdl-34431798
ABSTRACT
OBJECTIVES:
COVID-19 is a novel coronavirus that emerged in 2019 and is responsible for a global pandemic. Numerous neurologic manifestations have been described in the literature regarding COVID-19, but most studies are focused on the central nervous system. The authors have noted an association between prior COVID-19 infection and the development of a systemic neuropathy that manifests with asymmetric sensorimotor loss in the peripheral nervous system. We describe 4 cases of mononeuropathy multiplex that were diagnosed after COVID-19 infection.METHODS:
All patients included were treated for severe COVID-19 infection at New York Presbyterian Hospital and subsequently referred to the Columbia Peripheral Neuropathy Center for persistent neuropathy.RESULTS:
Patient history, COVID-19 disease course, and mononeuropathy multiplex diagnostic evaluation of the 4 patients are recounted.CONCLUSIONS:
We postulate a connection between COVID-19 and the development of mononeuropathy multiplex with implications in prognostication, rehabilitation strategies, and future treatments.
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Mononeuropathies
/
COVID-19
Type of study:
Diagnostic_studies
/
Etiology_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
J Clin Neuromuscul Dis
Journal subject:
FISIOLOGIA
/
NEUROLOGIA
Year:
2021
Document type:
Article